#AIDD #DrugDiscovery #DREAMChallenge #Target2035 #MachineLearning #DEL
8/8

🚀 Arrenca el nou projecte de IHI: #LIGAND-AI, liderat per @thesgc.bsky.social i Pfizer, per transformar el desenvolupament de fàrmacs mitjançant la IA
Albert Antolín, incorporat recentment al VHIO, colidera l’àrea de machine learning amb IBM
➡️ https://linke.to/LIGANDAI_Cat
#Target2035 #HorizonEurope

🚀 Arranca el nuevo proyecto de IHI: #LIGAND-AI, liderado por @thesgc.bsky.social y Pfizer, para transformar el
desarrollo de fármacos a través de la #IA
Albert Antolín, incorporado recientemente al VHIO, colidera el área de machine learning con IBM.
➡️ https://linke.to/LIGANDAI_Cast
#Target2035

New IHI project launches: #LIGAND-AI, led by @thesgc.bsky.social & Pfizer to build open datasets of protein–ligand interactions and train AI models for #DrugDiscovery
Albert Antolín, who recently joined VHIO, co-leads the machine learning work with IBM.

➡️ https://linke.to/LIGANDAI_Eng
#Target2035

🎉 The Chemical Probes Portal turns 10!
We’re honoured to be featured in Dr Dan Erlanson’s latest Practical Fragments blog, reflecting on a decade of advancing chemical biology and open science.

🔗 Read the blog: practicalfragments.blogspot.com/2025/08/the-...
#ChemicalProbes #Target2035

UCL, with @thesgc.bsky.social and scientists from 30 leading organisations, has published a landmark roadmap in @natrevchem.nature.com‬, outlining a global, open science strategy to scale up hit discovery efforts for every human protein. #Target2035 #DrugDiscovery
www.nature.com/articles/s41...

After 5 years of planning and pilot projects, Target2035, which aims to develop and share pharmacological probes for all human proteins by 2035, is coming out of stealth mode. Our Roadmap for accelerating small molecule hit discovery is now published.

rdcu.be/exxi7

Have you caught Episode 6 of the #Target2035 Podcast? 🎙️
Danette Daniels (@ FoghornTx) joins Milka Kostic, to dive into the power of #ProteinDegradation – what sets degraders apart, why #TPD is surging, and how we speed discovery.

Plus: championing #WomenInSTEM 💪

Also in this month's issue is an update on Target 2035 from @carrowsm.bsky.social, Stefan Knapp and colleagues covering the efforts of the EUbOPEN project which is contributing to the goals of #Target2035💡

Read the #OpenAccess article here⬇
pubs.rsc.org/en/content/a...

#Chemsky🧪

📢🎧 Listen to the first episode of ICR Professor Paul Workman’s interview with @target2035 podcast on the importance of the Chemical Probes Portal and their collaboration to develop a chemical probe for every human protein by 2035.
🎧 open.spotify.com/episode/7cn7...

🎙️ New podcast episode alert! Professor Paul Workman joins Opher Gileadi on the #Target2035 podcast to dive into the science of chemical probes. 🧪

🔍 What makes a great probe?
🛑 Common lab mistakes.
🌐 Learn about the Chemical Probes Portal.

🎧 Listen now 👇

Designing compounds with robots and AI will not accelerate drug discovery says @dereklowe.bsky.social (agreed). But designing great #ChemicalProbes using AI (eventually) and putting them in the hands of biologists just might. #Target2035

www.chemistryworld.com/opinion/robo...

🚨 Just Launched! Episode 1 of the Target 2035 Podcast Series 🎧
Join @LabScribbles as they chat with @CherylArrowsmi1, a trailblazer in chemical biology and co-founder of #Target2035. Discover the story behind this ambitious initiative for #OpenScience and #DrugDiscovery.
🎙️ Listen now: Link below 👇

The #Target2035 mission is to discover chemical tools for all human proteins by 2035. An ambitious and impactful mission!

An exciting #ReactomeResearchSpotlight!
In the feature article of the October 2024 issue of Drug Discovery Today titled "Chemical coverage of human biological pathways" by Kwak et al. describe the #Target2035 initiative!
Read more: reactome.org/content/reac...